Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.
A I Schafer, … , S E Rittenhouse, E W Salzman
A I Schafer, … , S E Rittenhouse, E W Salzman
Published July 1, 1986
Citation Information: J Clin Invest. 1986;78(1):73-79. https://doi.org/10.1172/JCI112576.
View: Text | PDF
Research Article

Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.

  • Text
  • PDF
Abstract

Studies have been performed on the biochemical mechanism of platelet activation induced by the fibrinolytic protease plasmin. In washed human platelets, greater than or equal to 1.0 caseinolytic units (CU/ml plasmin induced aggregation. Platelet [14C]serotonin release was stimulated by 1.0 CU/ml plasmin to an extent comparable to that induced by 1.0 U/ml thrombin. A dose- and time-dependent phosphorylation of the platelet 47,000- and 20,000-kD proteins was noted in 32PO4-labeled platelets incubated with plasmin; phosphorylation was not affected by extracellular Ca2+, but was completely inhibited by an increase in platelet cyclic AMP. Phosphorylation of these platelet proteins suggested that plasmin may act on platelets by stimulating a rise in cytosolic calcium concentration ([Cai2+]) and activating inositol phospholipid-dependent phospholipase C and protein kinase C. Using both quin2 fluorescence and aequorin luminescence as indicators, plasmin was found to elevate platelet [Cai2+] in the presence or absence of extracellular Ca2+. Phospholipase C activation was shown by the generation of [3H]diglyceride in [3H]arachidonic acid-labeled platelets and [32P]phosphatidic acid in 32PO4 labeled platelets exposed to plasmin. Plasmin did not induce formation of thromboxane A2 (TXA2). Only small amounts of this eicosanoid were detected late in the time course after plasmin stimulation. Our results indicate that plasmin causes platelet aggregation and secretion associated with phosphorylation of the 47,000- and 20,000-kD proteins, Ca2+ mobilization, and phospholipase C and protein kinase C activation.

Authors

A I Schafer, A K Maas, J A Ware, P C Johnson, S E Rittenhouse, E W Salzman

×

Total citations by year

Year: 2020 2018 2017 2012 2009 2008 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 Total
Citations: 1 1 1 1 1 1 1 2 1 1 2 2 2 1 3 6 7 7 6 11 8 13 7 8 6 3 103
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (103)

Title and authors Publication Year
Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases
C Pielsticker, MF Brodde, L Raum, K Jurk, BE Kehrel
International journal of molecular sciences 2020
Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review
L van der Vorm, J Remijn, B de Laat, D Huskens
TH Open 2018
Platelets in Thrombotic and Non-Thrombotic Disorders
P Gresele, NS Kleiman, JA Lopez, CP Page
Platelets in Thrombotic and Non-Thrombotic Disorders 2017
Plasminogen/plasmin influence on platelet aggregation
YM Roka-Moya, DD Zhernossekov, TV Grinenko
Biopolymers and Cell 2012
Regulation of plasmin-induced protease-activated receptor 4 activation in platelets
Y Mao, J Jin, JL Daniel, SP Kunapuli
Platelets 2009
Plasmin is involved in inflammation via protease-activated receptor-1 activation in human dental pulp
N Kamio, H Hashizume, S Nakao, K Matsushima, H Sugiya
Biochemical Pharmacology 2008
Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase
TT Hong, J Huang, BR Lucchesi
American journal of physiology. Heart and circulatory physiology 2006
A novel mechanism of plasmin-induced mitogenesis in fibroblasts
SK Mandal, LV Rao, TT Tran, UR Pendurthi
Journal of Thrombosis and Haemostasis 2005
Monitoring platelet function by PFA-100 closure time measurements during thrombolytic therapy of patients with myocardial infarction
A Kerényi, P Soltész, K Veres, G Szegedi, L Muszbek
Thrombosis Research 2005
Plasmin-induced Migration Requires Signaling through Protease-activated Receptor 1 and Integrin α 9 β 1
M Majumdar, T Tarui, B Shi, N Akakura, W Ruf, Y Takada
The Journal of biological chemistry 2004
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor
You fu Li, Frederick A Spencer, Richard C Becker
Journal of Thrombosis and Thrombolysis 2003
Plasmin-induced Migration of Endothelial Cells: A POTENTIAL TARGET FOR THE ANTI-ANGIOGENIC ACTION OF ANGIOSTATIN
T Tarui, M Majumdar, LA Miles, W Ruf, Y Takada
The Journal of biological chemistry 2002
Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44/42 Mitogen-Activated Protein Kinase–Dependent Signaling Pathway
UR Pendurthi, M Ngyuen, P Andrade-Gordon, LC Petersen, LV Rao
Arteriosclerosis, thrombosis, and vascular biology 2002
Platelet activation by sustained exposure to low-dose plasmin
AL Ervin, EI Peerschke
Blood Coagulation and Fibrinolysis 2001
Platelet activation by sustained exposure to low-dose plasmin:
AL Ervin, EI Peerschke
Blood Coagulation and Fibrinolysis 2001
On the mechanism of plasmin-induced platelet aggregation Implications of the dual role of granule ADP
A Ishii-Watabe
Biochemical Pharmacology 2000
Platelets
JN George
The Lancet 2000
Platelet microparticles: a wide-angle perspective
L Horstman
Critical Reviews in Oncology/Hematology 1999
The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron
ML Selley, MR Bartlett, AL Czeti, NG Ardlie
Atherosclerosis 1998
Human platelet activation by thrombolytic agents: Effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression
K Kawano, I Aoki, N Aoki, M Homori, A Maki, Y Hioki, Y Hasumura, A Terano, T Arai, H Mizuno, K Ishikawa*
American Heart Journal 1998
Unstable Coronary Artery Syndromes Pathophysiology, Diagnosis and Treatment
RL Wilensky
1998
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD
The Annals of Thoracic Surgery 1997
High-Molecular-Mass and Low-Molecular-Mass Kininogens Block Plasmin-Induced Platelet Aggregation by Forming a Complex with Kringle 5 of Plasminogen/Plasmin
TE Selim, HR Ghoneim, AB Uknis, RW Colman, RA Cadena
European Journal of Biochemistry 1997
Aprotinin Inhibits Plasmin-Induced Platelet Activation During Cardiopulmonary Bypass
O Shigeta, H Kojima, T Jikuya, Y Terada, N Atsumi, Y Sakakibara, T Nagasawa, T Mitsui
Circulation 1997
Platelets and Their Factors
F von Bruchhausen, U Walter
1997
Plasmin Is a Potent and Specific Chemoattractant for Human Peripheral Monocytes Acting Via a Cyclic Guanosine Monophosphate–Dependent Pathway
T Syrovets, B Tippler, M Rieks, T Simmet
Blood 1997
Bovine erythrocyte haemolysates enhance plasminogen activation by tissue-type plasminogen activator
M Yamada, T Horiuchi, T Oribe, S Yamamoto, I Sugie, P A Gentry
Veterinary Research Communications 1997
The effect of plasmin on platelet function
D Blockmans, H Deckmyn, LV Hove, J Vermylen
Platelets 1996
Cleavage of the thrombin receptor: identification of potential activators and inactivators
MA Parry, T Myles, J Tschopp, SR Stone
Biochemical Journal 1996
THE EFFECT OF CHOLESTEROL OXIDATION PRODUCTS ON HUMAN PLATELET AGGREGATION
ML Selley, JA McGuiness, NG Ardlie
Thrombosis Research 1996
Flow cytometric analysis of the prevention of platelet activation by tissue type plasminogen activator and streptokinase
T Pietrucha, J Golański, Z Baj, H Tchórzewski, J Greger, C Watala
Fibrinolysis 1996
Plasmin-platelet interaction involves cleavage of functional thrombin receptor
M Kimura, TT Andersen, JW nd, WF Bahou, A Aviv
American journal of physiology. Cell physiology 1996
Evidence for cAMP-dependent Platelet Ectoprotein Kinase Activity That Phosphorylates Platelet Glycoprotein IV (CD36)
M Hatmi, JM Gavaret, I Elalamy, BB Vargaftig, C Jacquemin
The Journal of biological chemistry 1996
High Concentrations of Active Plasminogen Activator Inhibitor-1 in Porcine Coronary Artery Thrombi
WP Fay, JG Murphy, WG Owen
Arteriosclerosis, thrombosis, and vascular biology 1996
Immunopharmacology of Platelets
MH Kroll, AI Schafer
Immunopharmacology of Platelets 1995
Streptokinase and APSAC inhibit platelet aggregation in vitro by fibrinogenolysis: Effect of plasma fibrinogen degradation products X and E
J Lebrazi, M Abdelouahed, M Mirshahi, MM Samama, T Lecompte
Fibrinolysis 1995
Platelets and Platelet Inhibitors in Acute Myocardial Infarction
SG Kamat, NS Kleiman
Cardiology Clinics 1995
Arterial Thrombosis for the Clinician
RC Becker
Cardiology Clinics 1995
Improving the efficacy and stability of coronary reperfusion following thrombolysis: Exploring the thrombin hypothesis
RC Becker
Journal of Thrombosis and Thrombolysis 1995
Achieving optimal reperfusion without adjunctive antithrombotic therapy: Novel thrombolytic dosing strategies
RC Becker
Journal of Thrombosis and Thrombolysis 1995
Fibrinolysis Inhibits Shear Stress–Induced Platelet Aggregation
SG Kamat, AD Michelson, SE Benoit, JL Moake, D Rajasekhar, JD Hellums, MH Kroll, AI Schafer
Circulation 1995
Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion
RC Becker
Clinical Cardiology 1994
Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells
JS Turner, GT Redpath, JE Humphries, SL Gonias, SR Vandenberg
Biochemical Journal 1994
Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist
BR Lucchessi, WE Rote, EM Driscoll, DX Mu
British Journal of Pharmacology 1994
Lys-and Glu-plasminogen potentiate the inhibitory effect of recombinant tissue plasminogen activator on human platelet aggregation
LY Chen, JL Mehta
Thrombosis Research 1994
The Modern Era of Coronary Thrombolysis
RC Becker
1994
Characterization of the plasminogen receptors of normal and rheumatoid arthritis human synovial fibroblasts
M Gonzalez-Gronow, G Gawdi, SV Pizzo
The Journal of biological chemistry 1994
Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets
MA Orchard, CS Goodchild, CR Prentice, JA Davies, SE Benoit, LJ Creighton-Kemsford, PJ Gaffney, AD Michelson
British Journal of Haematology 1993
PPACK attenuates plasmin-induced changes in endothelial integrity
LE Rabbani, MT Johnstone, MA Rudd, P Devine, D George, J Loscalzo
Thrombosis Research 1993
Reciprocating autocatalytic interactions between platelets and the activation system
H Ouimet, J Loscalzo
Thrombosis Research 1993
The influence of recombinant tissue-type plasminogen activator and plasmin on platelet aggregation: a quenched-flow study
S Dittmar, AR Gear
Fibrinolysis 1993
Effects of the novel recombinant plasminogen activator BM 06.022 on human platelet aggregation in vitro
U Martin, G Sponer, K Strein
Fibrinolysis 1993
Fibrinogen degradation products generation is the major determinant of platelet inhibition induced by plasminogen activators in platelet-rich plasma
P Parise, J Hauert, A Iorio, P Callegari, GG Nenci
Fibrinolysis 1993
Platelet function during thrombolytic therapy with anistreplase
JJ Hoffmann, JJ Bonnier, PG Melman, I Bartholomeus, JE Couvée, R Standring, R Fears
Fibrinolysis 1993
Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits
G Montrucchio, G Alloatti, F Mariano, E Lupia, PG Lucchina, E Musso, G Emanuelli, G Camussi
Circulation research 1993
Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells
G Montrucchio, S Bergerone, F Bussolino, G Alloatti, L Silvestro, E Lupia, A Cravetto, MD Leo, G Emanuelli, G Camussi
Circulation 1993
Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets
MC Shen, CM Teng, A Takada
1993
Plasminogen activation stimulates an increase in intracellular calcium in human synovial fibroblasts
M Gonzalez-Gronow, G Gawdi, SV Pizzo
The Journal of biological chemistry 1993
“Plasminogen steal” and clot lysis
SR Torr, DA Nachowiak, S Fujii, BE Sobel
Journal of the American College of Cardiology 1992
Inhibition of cell adhesion by high molecular weight kininogen
S Asakura, RW Hurley, K Skorstengaard, I Ohkubo, DF Mosher
The Journal of Cell Biology 1992
Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide
RN Puri, CJ Hu, R Matsueda, H Umeyama, RW Colman
Thrombosis Research 1992
Thrombin antagonists and antiplatelet agents
RC Becker
The American Journal of Cardiology 1992
Platelet function after in vivo and in vitro treatment with thrombolytic agents
G Bertolino, P Noris, M Previtali, G Gamba, M Ferrario, N Montani, CL Balduini
The American Journal of Cardiology 1992
Current Concepts in Coronary Thrombolysis
PR Eisenberg
Hematology/Oncology Clinics of North America 1992
In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis
I Gouin, T Lecompte, MC Morel, J Lebrazi, PW Modderman, C Kaplan, MM Samama
Circulation 1992
Platelet-dependent thrombin generation after in vitro fibrinolytic treatment
DL Aronson, P Chang, CM Kessler
Circulation 1992
Streptokinase Inhibits Acute Platelet Thrombus Formation in Stenosed Dog Coronary Arteries
JD Folts, BS Schwartz, MH Kroll, AI Schafer
Platelets 1991
Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor
SR Torr, EJ Haskel, PF VonVoigtlander, SR Bergmann, DR Abendschein
Journal of the American College of Cardiology 1991
Effect of tranexamic acid on platelet ADP during extracorporeal circulation
G Soslau, J Horrow, I Brodsky
American Journal of Hematology 1991
Platelets and Fibrinolysis
B Pasche, J Loscalzo
Platelets 1991
Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics
M Hatmi, B Haye, JM Gavaret, BB Vargaftig, C Jacquemin
British Journal of Pharmacology 1991
The dependence of activation of platelets by a plasminogen activator on the evolution of thrombin activity
SR Torr, PR Eisenberg, BE Sobel
Thrombosis Research 1991
Platelet activation in the pathogenesis of unstable angina: Importance in determining the response to plasminogen activators
DJ Fitzgerald
The American Journal of Cardiology 1991
Recombinant tissue-type plasminogen activator: Current concepts and guidelines for clinical use in acute myocardial infarction. Part II
RC Becker, R Harrington
American Heart Journal 1991
Effect of intravenous prostaglandin E1 on thrombolysis induced by human recombinant tissue-type plasminogen activator in feline peripheral arterial thrombosis
WR Humphrey, RG Schaub
Fibrinolysis 1991
Disseminated Intravascular Coagulation: Pathogenesis and Management
AH Schmaier
Journal of Intensive Care Medicine 1991
Increase in the cytosolic concentration of calcium in platelets of diabetics type II
D Tschöpe, P Rösen, FA Gries
Thrombosis Research 1991
Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase
KJ Winters, SA Santoro, JP Miletich, PR Eisenberg
Circulation 1991
Adjuvant antiplatelet strategies in coronary thrombolysis
RC Becker, JM Gore
Circulation 1991
Effects of Streptokinase and Recombinant Tissue Plasminogen Activator on Platelet Aggregation in Whole Blood
S Heptinstall, DC Berridge, H Judge
Platelets 1990
Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids
ME Brezinski, CN Serhan
Proceedings of the National Academy of Sciences 1990
Platelets and Thrombolytic Therapy
JS Flier, LH Underhill, BS Coller
New England Journal of Medicine 1990
The nature of interactions between tissue-type plasminogen activator and platelets
SR Torr, KJ Winters, SA Santoro, BE Sobel
Thrombosis Research 1990
Plasminogen receptors in the mediation of pericellular proteolysis
EF Plow, LA Miles
Cell Differentiation and Development 1990
Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain
RN Puri, FX Zhou, RF Colman, RW Colman
American journal of physiology. Cell physiology 1990
Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins
MA Rudd, D George, P Amarante, DE Vaughan, J Loscalzo
Circulation research 1990
Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium
SK Lo, TJ Ryan, N Gilboa, L Lai, AB Malik
Journal of Clinical Investigation 1989
Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation
DC Berridge, ME Burgess-Wilson, JC Westby, BR Hopkinson, GS Makin
British Journal of Surgery 1989
Platelet activation by oxidatively modified low density lipoproteins
NG Ardlie, ML Selley, LA Simons
Atherosclerosis 1989
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator
DJ Fitzgerald, GA Fitzgerald
Proceedings of the National Academy of Sciences 1989
Attenuation of the inhibitory effect of prostacyclin on platelet function after tissue plasminogen activator or streptokinase infusion in the rabbit
RJ Shebuski, JC Bloom, TS Sellers, T Fujita, B Storer, S Horohonich, KL Fong, EH Ohlstein
Fibrinolysis 1989
Interactions between pharmacologic concentrations of plasminogen activators and platelets
ET Fry, AM Grace, BE Sobel
Fibrinolysis 1989
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator
DM Kerins, L Roy, GA FitzGerald, DJ Fitzgerald
Circulation 1989
Thrombolysis in the Management of Acute Myocardial Infarction and Unstable Angina Pectoris:
J Loscalzo
Drugs 1989
Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle
M KNORR, R LOCHER, E VOGT, W VETTER, LH BLOCK, F FERRACIN, H LEFKOVITS, A PLETSCHER
European Journal of Biochemistry 1988
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism
LH Block, M Knorr, E Vogt, R Locher, W Vetter, P Groscurth, BY Qiao, D Pometta, R James, M Regenass
Proceedings of the National Academy of Sciences 1988
Tissue-type plasminogen activator inhibits aggregation of platelets
T Mizuta, C Imai
Life Sciences 1988
Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis
LA Miles, EF Plow
Fibrinolysis 1988
Tissue Plasminogen Activator
JA Oates, AJ Wood, J Loscalzo, E Braunwald
New England Journal of Medicine 1988
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction
DJ Fitzgerald, F Catella, L Roy, GA FitzGerald
Circulation 1988
Tissue plasminogen activator promotes platelet disaggregation in plasma
J Loscalzo, DE Vaughan
Journal of Clinical Investigation 1987
Impaired thromboxane synthesis in preactivated human blood platelets: Agonist-specific, irreversible desensitization to thrombin
HJ Reimers, RK Baker, JH Joist
Thrombosis Research 1987
Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit
EH Ohlstein, B Storer, T Fujita, RJ Shebuski
Thrombosis Research 1987

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts